挪威和瑞典在COVID-19大流行期间的死亡率2020-22:一项比较研究
Per-Henrik Zahl1, Örjan Hemström2, Rune Johansen1
1Norwegian Institute of Public Health, Division of Mental and Physical Health Oslo, Norway.
Journal of infection and public health
|January 23, 2024
概括
瑞典的COVID-19死亡率明显高于挪威,经过调整后的差异在30个月后缩小到30%. 这凸显了不同流行病减缓策略对公共卫生结果的影响.
科学领域:
- 流行病学 流行病学
- 公共卫生政策 公共卫生政策
背景情况:
- 挪威实施了严格的COVID-19封锁和边境管制,而瑞典则采取了更宽松的做法.
- 这些对比的策略导致了2020年COVID-19死亡人数的巨大差异:挪威的477人与瑞典的9,737人相比.
研究的目的:
- 为了比较挪威和瑞典之间的COVID-19死亡率.
- 分析不同公共卫生干预措施对流行病结果的影响.
主要方法:
- 利用了2020-2022年每周的COVID-19和总死亡数据,与2015-2019年过度死亡率计算的基线数据进行比较.
- 在高传播期间使用过度死亡率作为COVID-19死亡的代理,并在过度死亡率由于流离失所而变得负面时调整为报告偏差.
主要成果:
- 在研究期间,瑞典记录了17521例COVID-19死亡,挪威为4272例.
- 瑞典与挪威的COVID-19死亡的粗率比率在2022年底为2.11.
- 在调整了死亡率,流离失所和封锁措施后,该比率下降到1.35,这表明挪威大约挽救了2025人的生命.
结论:
- 无论是直接的COVID-19死亡人数还是过度死亡率估计都可能存在偏见.
- 经过调整后的分析显示,瑞典和挪威之间的死亡率差异随着时间的推移而减少,瑞典经历了大约30%的高死亡率,大流行后30个月.
相关概念视频
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Life Tables
105
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
105
Censoring Survival Data
95
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
95
Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128


